Here are four points:
1. The shares were sold at $52.43 per share for a total value of $308,369.
2. The 50-day moving average price of the shares is $50.24, and the 200-day moving average price is recorded at $50.67.
3. The current rating of the shares is “outperform.”
4. The company has a market cap of $2.56 billion.
More articles on devices:
Cytos Biotechnology and Kuros Biosurgery merge — 6 takeaways
Zacks downgrades Mazor Robotics to ‘hold’ rating: 5 facts
InVivo receives patents for instrument aiding treatment of chronic spine injuries
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
